Table 1.
Baseline patient demographics
| Demographic | Short-course group (n = 33) | Long-course group (n = 19) | p-value |
|---|---|---|---|
| Female—n (%) | 33 (100%) | 19 (100%) | |
| Age (years) – median (IQR) | 76 (69–82) | 73 (63–78) | .299 |
| Race—n (%) | |||
| White | 26 (78.8%) | 16 (84.2%) | |
| Black/African American | 5 (15.2%) | 2 (10.5%) | |
| Other/Unknown | 2 (3.7%) | 1 (5.3%) | |
| BMI kg/m 2 – median (IQR) | 25.79 (22.94–31.23) | 31.97 (25.23–37.79) | .049 |
| Maximum WBC – median (IQR) | 7.18 (5.50–9.94) | 8.27 (5.85–9.33) | .470 |
| Max temperature (degrees celsius) – median (IQR) | 36.9 (36.8–37.1) | 37.0 (36.8–37.4) | .710 |
| Serum creatinine on admission (mg/dl) – median (IQR) | 1.02 (.82–1.58) | 1.25 (.82–1.65) | .857 |
| Charlson Co-morbidity Index (CCI) – median (IQR) | 7 (4–9.50) | 7 (5–10) | .334 |
| Diagnosis of immunocompromised—n (%) | 2 (6.1%) | 2 (10.5%) | .617 |
| History of UTI—n (%) | 5 (15.2%) | 3 (15.8%) | 1.000 |